Business Valuation vs Fundraising Valuation: The Gap Founders Ignore

Business Valuation vs Fundraising Valuation: The Gap Founders Ignore

Your fundraising round closes at a Rs. 60 crore post-money valuation. Your ESOP committee prices the next grant at a "reasonable discount" to that number. Your offshore lead investor expects an FC-GPR filing on the FIRMS portal within thirty days of allotment. And your finance head is documenting a related-party loan secured against shares. All four of these transactions touch a different legal definition of "value" — and none of them is simply the number on your term sheet. In India in 2026, treating fundraising valuation as a universal proxy for every compliance purpose is a shortcut that generates tax demands, FEMA compounding notices, and broken ESOP pools.

Two Lenses, One Company — Why They Diverge

A fundraising valuation is a negotiated commercial number. Investor and founder agree on how much of the company a given cheque buys. It reflects market sentiment, comparable rounds in the sector, the investor's return hurdle, and the narrative on the pitch deck. It is not derived from a structured methodology — it is what a willing buyer pays a willing seller under conditions of relative information asymmetry and commercial urgency.

A business valuation — in the Indian regulatory sense — is a structured estimate produced by a Registered Valuer (RV) enrolled with the Insolvency and Bankruptcy Board of India (IBBI) under Section 247 of the Companies Act 2013, read with the IBBI (Registered Valuers and Valuation Rules), 2017. The RV applies a recognised methodology — DCF (Discounted Cash Flow), CCM (Comparable Companies Method), or NAV (Net Asset Value) — and produces a formal report, signed in their individual capacity, with stated assumptions, sensitivity tables, and a clear "as-at" date.

The fundraising number is your headline. The business valuation governs your filings, your taxes, and your regulatory standing. The gap between the two can be small or enormous depending on your business stage, your method, and your assumptions — but it is almost always non-zero, and it almost always matters in at least one of the contexts described below.

Where the Gap Creates Real Legal and Tax Risk

1. Section 56(2)(viib) — Angel Tax: Abolished Going Forward, But Past Assessments Are Live

Section 56(2)(viib) of the Income-tax Act 1961 taxed the excess of issue price over Fair Market Value (FMV) as income in the hands of the issuing company when shares were allotted to resident investors at a premium above FMV. Finance (No. 2) Act 2024 omitted this provision effective from FY 2024-25 — shares issued from 1 April 2024 onwards are not subject to angel tax.

However, if your company raised from resident investors in FY 2021-22 through FY 2023-24 without a compliant Rule 11UA valuation report dated before allotment, CBDT scrutiny for those assessment years is ongoing and active. DPIIT-recognised startups enjoyed safe harbour under a CBDT notification, but companies without recognition at the time of allotment — or those that applied for DPIIT recognition only after receiving an assessment notice — have been facing demands.

The practical lesson for 2026: Angel tax is gone prospectively, but your legacy rounds need documentary support ready for assessment. And the Rule 11UA discipline — a valuation report dated before allotment, not after — remains the correct practice for every other compliance purpose discussed in this article.

2. FEMA NDI Rules — Foreign Investor Pricing Is Non-Negotiable

The Foreign Exchange Management (Non-Debt Instruments) Rules, 2019 (NDI Rules) require that equity instruments issued to non-resident investors be priced at not less than FMV determined by a SEBI-registered Merchant Banker or a Chartered Accountant using an internationally accepted pricing methodology. Three points that founders routinely get wrong:

• Timing is everything. The valuation certificate must be obtained before allotment, not as an afterthought filed with the FC-GPR. An after-the-fact certificate filed on the FIRMS portal is technically non-compliant and invites compounding under Section 15 of FEMA.
• Recency matters. A valuation done six months before the current allotment is not acceptable for a new issuance. Get a fresh certificate for each allotment event.
• Method and signatory. Both DCF and CCM are internationally accepted and appropriate for unlisted companies. The report must explicitly name the methodology and be signed by the certifying professional in their own name, not the firm name alone.

The FC-GPR must be filed on the RBI's FIRMS portal (firms.rbi.org.in) within 30 days of allotment of equity instruments to a non-resident. The share-price certificate is a mandatory attachment. Even if the pricing is compliant, a late FC-GPR filing independently attracts compounding.

3. ESOP Fair Market Value — The Cost Centre Nobody Tracks

ESOPs granted under a board-approved plan are taxed as a perquisite under Section 17(2)(vi) of the Income-tax Act. The perquisite value is: (FMV at exercise date − exercise price) × number of shares exercised. This is added to the employee's salary and taxed at slab rates in the year of exercise.

For FY 2026-27 (AY 2027-28), with the new tax regime as default, a senior employee crossing Rs. 15 lakh in total income and exercising ESOPs will pay approximately 30% plus applicable surcharge and cess on the perquisite component — an effective rate that can touch 34–39% depending on total income.

If your company has never obtained an FMV valuation report at each material event — a new funding round, an ESOP pool expansion, a co-founder's departure, or a material business pivot — your strike prices may be set arbitrarily, your perquisite computations incorrect, and your TDS obligations under Section 192 understated. An understated TDS makes the company an assessee-in-default under Section 201, with interest liability running at 1.5% per month from the date of deduction.

For employees of DPIIT-recognised eligible startups, Section 192(1C) defers TDS on ESOP perquisite to the earliest of: (a) sale of shares, (b) cessation of employment, or (c) five years from allotment. This is a cash-flow benefit for employees — it does not reduce the underlying tax liability, only defers the collection point.

4. Transfer Pricing and Related-Party Share Transactions

When shares of an Indian company change hands between associated enterprises — a founder transferring shares to a group holding company, a restructuring involving share swaps, or a loan from a subsidiary secured against shares — the arm's-length price requires documentation under Section 92 of the Income-tax Act. The domestic transfer pricing threshold is transactions exceeding Rs. 20 crore in a year; all international transactions with associated enterprises require documentation regardless of amount.

Using the last fundraising valuation as the "arm's-length price" without a current Registered Valuer report is a position that will not survive Transfer Pricing Officer scrutiny.

5. Mergers, Demergers and Buy-backs

The NCLT process for mergers and demergers under Sections 230–232 of the Companies Act requires a Registered Valuer report for the share-exchange ratio. Form NCLT-1 and the explanatory statement filed with the MCA V3 portal (www.mca.gov.in) must reference this report. Buy-backs under Section 68 require a valuation opinion on the maximum permissible buy-back price relative to book value. In each case, the last fundraising valuation is not a legally sufficient substitute for a structured Registered Valuer computation.

The Three Valuation Methods Regulators Accept

DCF — Discounted Cash Flow

DCF projects free cash flows over a 5–10 year explicit forecast period, adds a terminal value, and discounts the total to present value using a Weighted Average Cost of Capital (WACC). For unlisted Indian startups, the WACC typically ranges between 25% and 40%, reflecting the illiquidity premium, execution risk, and stage discount applied over listed-equity benchmarks. DCF is appropriate for post-revenue companies with identifiable unit economics. For pre-revenue companies, terminal growth assumptions dominate the output — a well-prepared report stress-tests these in explicit sensitivity tables.

CCM — Comparable Companies Method

CCM applies revenue or EBITDA multiples derived from a basket of comparable listed companies — or recent private transactions — to your own metrics, with discounts for size, liquidity, and stage. In Indian SaaS markets in 2026, publicly listed software peers may trade at 6–10x NTM (next twelve months) revenue; private unlisted companies typically carry a 20–30% illiquidity discount on top of a further stage-based adjustment. CCM is credible when you have genuine comps and actual revenue; it is commonly run alongside DCF as a cross-check in Registered Valuer reports.

NAV — Net Asset Value

NAV is simply the book value of net assets. It is backward-looking, conservative, and rarely appropriate for a growth-stage technology company. Its legitimate uses are for asset-heavy businesses, holding companies, or wind-down scenarios. Rule 11UA under the Income Tax Rules provides for a net-asset-based computation as a floor, but DCF is the operative method for most funded startups where going-concern value exceeds book value by a material margin.

Worked Example 1: How a Rs. 10 Crore Round Created a Rs. 2.16 Crore Tax Exposure

Hypothetical illustration of Section 56(2)(viib) mechanics for FY 2022-23 — a year now under active CBDT assessment.

A gaming startup raises its first institutional round in October 2022. It issues 2,000 Compulsorily Convertible Preference Shares (CCPS) at Rs. 50,000 per share to a resident HNI, for total consideration of Rs. 10 crore. The post-money implied valuation is approximately Rs. 50 crore. The company had not obtained DPIIT recognition at the time of allotment.

On receiving a CBDT notice in FY 2024-25, a CA prepares a Rule 11UA valuation using DCF based on Rs. 80 lakh in revenue and projected growth, yielding an FMV of Rs. 20,000 per share — an Rs. 8 crore enterprise value — as at the October 2022 allotment date.

DPIIT recognition, had it been obtained before allotment, would have provided safe harbour and eliminated the demand entirely. The recognition application is filed online, takes 2–4 weeks, and is free. The founders had assumed it was needed only for the DPIIT IP box regime — a common and expensive misreading.

Worked Example 2: The ESOP FMV Mismatch and TDS Default

A senior product manager receives 1,000 ESOPs in February 2023 at a strike price of Rs. 10 per share. She exercises 500 shares in March 2026 following a Series B close.

The company's IBBI Registered Valuer (SFA category) runs a fresh DCF in March 2026, yielding FMV of Rs. 800 per share.

If the company had no current FMV report and used "the last round's implied per-share price" set 18 months earlier — say Rs. 450 — the perquisite would be computed at Rs. 2,20,000 instead of Rs. 3,95,000. The TDS shortfall of approximately Rs. 52,500 makes the company an assessee-in-default under Section 201, carrying interest at 1.5% per month. Multiply this across 30 employees exercising in the same quarter, and the exposure becomes material.

The Document Trail You Must Maintain

Here is the standing compliance pack every funded company needs, organised by trigger event:

At each funding round (resident or non-resident):

1. IBBI-registered Valuer (SFA category) report — dated before allotment, covering the method and assumptions
2. Board resolution recording FMV, allotment price, and basis — filed as MGT-14 on MCA V3 if a special resolution is involved
3. For non-resident investors: SEBI-registered Merchant Banker or CA pricing certificate — mandatory FC-GPR attachment; file on FIRMS portal within 30 days

For ESOP administration (ongoing):

1. FMV report at each grant cycle — Rule 11UA computation supporting the strike price
2. FMV report at each vesting/exercise date — basis for Section 192 TDS calculation
3. ESOP plan and grant letters with board approval trail

Entity-level standing documents:

1. DPIIT recognition certificate — obtained before the first resident-investor allotment above FMV; renew annually if required
2. Transfer pricing documentation — updated when related-party share transactions exceed thresholds
3. FC-GPR portal acknowledgements — timestamped proof of timely FEMA filing

Keep all valuation reports as PDFs with metadata intact. Auditors, investors conducting due diligence, and CBDT assessment officers will ask for these in chronological order. The absence of a pre-allotment valuation is one of the first red flags in any tax due diligence or FEMA audit.

Down Rounds — When the Gap Bites Simultaneously

When your next round prices below the previous one — a down round — the gap between historical fundraising valuations and current business valuation becomes visible across multiple pain points at once.

Anti-dilution ratchets: Broad-based weighted-average clauses in earlier term sheets trigger additional share issuances to earlier investors. The computation of the adjustment itself requires the new round price, which the Registered Valuer report must support. An undocumented or inflated new-round valuation will be challenged by earlier investors whose ratchet benefit depends on the precise numbers.

Underwater ESOPs: Strike prices set at the Series A FMV — say Rs. 6,000 per share — are now above the Series B FMV of Rs. 4,500. Employees won't exercise; the ESOP pool loses its retention value. Repricing requires a fresh FMV report, a new board and shareholder approval (filed on MCA V3), and revised vesting schedules. Without a proper FMV report anchoring the repriced strike price, you risk creating a taxable perquisite at grant rather than at exercise — an adverse tax consequence that makes the repricing counterproductive.

ROFR and secondary transfers: Existing shareholders exercising their Right of First Refusal on a proposed secondary transfer need a reliable FMV benchmark to determine whether an incoming offer is at arm's length. A stale or self-serving valuation that understates FMV on a ROFR notification can be challenged by other shareholders and, if a non-resident is involved, by the RBI at compounding.

Pitfalls to Avoid

• Backdated valuation reports: A report dated before allotment but actually prepared weeks later is not a technicality — it is a fabricated document. CBDT assessment officers cross-check report dates against email metadata, board resolution timestamps, and bank credit dates. The risk is reclassification from technical non-compliance to misrepresentation.
• Reusing a single report for multiple allotments: A FEMA NDI certificate prepared for one allotment does not cover a subsequent allotment six months later, even if the company's business has not materially changed. Every allotment to a non-resident needs its own certificate.
• Conflating FEMA reports with ESOP FMV reports: The FEMA NDI certificate uses internationally accepted methods; the ESOP FMV uses Rule 11UA methodology. These may yield different FMV figures from identical data — and they are correct to do so because they serve different statutory purposes. Use the right report for the right filing.
• Assuming DPIIT recognition has retrospective effect: The Section 56(2)(viib) safe harbour applies to allotments made after recognition is granted. If the allotment preceded recognition, the 11UA valuation must independently justify the issue price.
• Ignoring material events between rounds: A significant new contract, loss of a key customer, a product pivot, or a founding-team departure can shift FMV materially. Issuing ESOPs or transferring shares at a stale FMV inherited from the last round creates a valuation lag that both employees and tax officers will notice.
• Treating convertible instruments as valuation-neutral events: SAFEs, OCDs, and CCDs issued to non-residents may attract FEMA pricing requirements at conversion. Review the instrument terms before assuming the conversion is a documentation-free event.

Key Takeaways

• Fundraising valuation and business valuation are legally distinct: one is a commercial negotiation, the other is a documented computation under a specific regulatory framework — Companies Act Section 247, Income-tax Rule 11UA, or FEMA NDI Rules.
• *FEMA NDI Rules require a FMV certificate before every allotment to non-residents* — obtain a fresh Merchant Banker or CA report each time and file FC-GPR on the FIRMS portal within 30 days of allotment.
• ESOP perquisite is taxed under Section 17(2)(vi) at slab rates in the year of exercise; TDS under Section 192 must be computed using a current, documented FMV — a stale report makes your company an assessee-in-default.
• Section 56(2)(viib) is abolished for shares issued from 1 April 2024, but CBDT assessments for FY 2021-22 to FY 2023-24 are active — maintain old valuation reports and DPIIT recognition evidence as part of your litigation-readiness file.
• A down round simultaneously triggers anti-dilution ratchets, underwater ESOPs, and ROFR complications — all of which require an updated Registered Valuer report as the anchor document, not the fundraising headline.
• Backdated, stale, or purpose-mismatched valuation reports are worse than no report — they convert a technical compliance gap into a potential allegation of document fabrication.
• Maintain a standing compliance pack updated after each material event: IBBI-SFA Registered Valuer report, FEMA NDI pricing certificate, ESOP FMV schedule, FC-GPR acknowledgements from FIRMS, and your DPIIT recognition certificate. This is not a round-closing formality — it is a living document set that every subsequent audit, due diligence, and assessment will test.